CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer
View abstract on PubMed
Summary
This summary is machine-generated.The transcription factor CUX1 promotes pancreatic cancer cell survival by inhibiting apoptosis. Silencing CUX1 enhances chemoresistance and reduces tumor growth, offering a potential therapeutic target for pancreatic cancer.
Area Of Science
- Molecular biology
- Cancer research
- Cell signaling
Background
- The transcription factor CUT homeobox 1 (CUX1) regulates cell differentiation and cell cycle.
- CUX1 modulates cancer cell invasiveness and may play a role in chemoresistance.
- Expression profiles suggest CUX1 involvement in drug resistance in pancreatic cancer.
Purpose Of The Study
- To characterize the effect of CUX1 on apoptosis in pancreatic cancer.
- To investigate the regulation of CUX1 by signaling pathways involved in drug resistance.
- To evaluate CUX1's role in pancreatic cancer cell survival in vitro and in vivo.
Main Methods
- Analyzed CUX1's effect on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)- and drug-induced apoptosis using overexpression and knock-down.
- Examined CUX1 regulation by phosphatidylinositol-3-kinase (PI3K)/Akt signaling at mRNA and protein levels.
- Assessed CUX1 knock-down efficacy in vivo using nanoparticle-complexed small interfering RNA (siRNA) in a murine xenograft model and evaluated CUX1 expression in human tissues.
Main Results
- CUX1 knock-down significantly enhanced apoptosis, indicated by increased poly ADP-ribose polymerase (PARP) cleavage and caspase activity.
- CUX1 overexpression inhibited apoptosis, associated with BCL2 upregulation and tumor necrosis factor alpha downregulation.
- CUX1 is overexpressed in pancreatic cancers, its expression is induced by Akt signaling, and its silencing reduced tumor growth and increased apoptosis in vivo.
Conclusions
- CUX1 is a significant mediator of tumor cell survival in pancreatic cancer.
- Targeting CUX1 may represent a novel therapeutic strategy for pancreatic cancer.
- CUX1's role in chemoresistance highlights its importance in pancreatic cancer progression.